Soman-induced Convulsions in Rats Terminated with Pharmacological Agents after 45 min: Neuropathology and Cognitive Performance
Section snippets
INTRODUCTION
Exposure to the organophosphorus nerve agent soman causes a progression of toxic signs including hypersecretion, respiratory distress, tremor, seizures/convulsions, coma, and death (Taylor, 1985). These toxic effects are due to irreversible inhibition of acetylcholinesterase, the enzyme that hydrolyzes acetylcholine. Excessive amounts of acetylcholine lead to over-stimulation of muscarinic and nicotinic receptors. Increased cholinergic activity in the brain can induce the first phase of
Subjects
Sixty-six male Wistar rats from a commercial supplier (Møllegaard Breeding Laboratories, Denmark) weighing 280–330 g served as subjects. The experiments were approved by the National Animal Research Authority. The animals were housed individually and had free access to commercial rat pellets and water, unless otherwise described for behavioral testing. The rats were handled individually 5 days before treatment and 2–5 days following treatment, being allowed to explore a table top (80 × 60 cm) for
Histology
In the Fluoro-Jade stained sections, the background contrast was adjusted to enhance the distinctness of cell elements. For this reason, a brighter background color was convenient for intact tissue, whereas a darker background color made the fluorescent, degenerating cell bodies more evident.
Among the convulsing rats (n = 14), tremendous individual differences were seen in terms of neuropathology: from none to severe degeneration (Fig. 1). In five rats, the neuropathology score was 0, whereas
DISCUSSION
The results from the present study showed that the triple regimen consisting of procyclidine, diazepam and pentobarbital was able to terminate soman-induced convulsions 45 min after onset. The neuropathology caused by soman plus convulsions varied enormously from none in 36% of the rats to as much as 30% damage in the index areas (hippocampus, amygdala, and piriform cortex). The brain lesions in the neuropathology group resulted in cognitive impairment in the novelty test and the discrimination
REFERENCES (39)
- et al.
d-Serine alleviates retrograde amnesia of a visual discrimination task in rats with a lesion of the perirhinal cortex
Brain Res
(2003) - et al.
Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats
Pharmacol Biochem Behav
(1993) - et al.
Early dendritic changes in hippocampal pyramidal neurones (field CA1) of rats subjected to acute soman intoxication: a light microscopic study
Brain Res
(1991) - et al.
Neurotoxic lesions of the perirhinal cortex do not mimic the behavioural effects of fornix transection in the rat
Behav Brain Res
(1996) - et al.
Effects of combinational prophylactics composed of physostigmine and procyclidine on soman-induced lethality, seizures and brain injuries
Environ Toxicol Pharmacol
(2002) - et al.
Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures: influence of septal cholinoceptive cells
Neurosci Lett
(1992) - et al.
Medical management of organophosphate-induced seizures
J Physiol (Paris)
(1998) - et al.
Atropine and/or diazepam therapy protects against soman-induced neuronal and cardiac pathology
Fundam Appl Toxicol
(1989) - et al.
Pharmacological modulation of soman-induced seizures
Neurosci Biobehav Rev
(1993) - et al.
Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology
Neurosci Biobehav Rev
(1997)